These results, together with a preceding report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 guidance the strategy of focusing on ACKR3 as a novel approach to modulate the opioid program, which could open new therapeutic avenues for opioid-associated disorders. Researchers believe that blocking this https://heywoodw812che9.ttblogs.com/profile